South Wales, Sept. 25 -- United Kingdom Intellectual Property Office (UKIPO) has registered trademark "AGALZYME" on Sept. 14. The details about the trademark application no. UK00004445090 published in the journal no. 2026/039 (Sept. 25).
With Simmons & Simmons LLP as representative, BIOSIDUS S.A.U. filed the trademark application for the below mentioned good(s)/service(s).
Class 5 : A medicinal product for human use indicated for the treatment of fabry disease.
The original document can be viewed at: http://www.ipo.gov.uk/cgi-bin/redirect.cgi?type=tmj&link=6¶m1=UK00004445090
Disclaimer: Curated by HT Syndication.
